1 . Mice lacking molecules associated with dying cell clearance develop SLElike disease 2 , and phagocytes from patients with SLE often display defective clearance and increased inflammatory cytokine production when exposed to dying cells in vitro. Previously, we 3-6 and others LAP is a process in which some, but not all components of the autophagy machinery conjugate LC3 to phosphatidylethanolamine directly on the phagosome membrane 3, 4, 6, 7, 10 . The lipidated LC3 (LC3-II) then facilitates lysosomal fusion and cargo destruction. Both LAP and canonical autophagy require ATG7, ATG3, ATG5, ATG12, and ATG16L for LC3 lipidation 4, 5 . However, unlike autophagy, LAP proceeds independently of the pre-initiation complex containing ULK1 and FIP200 (also known as RB1CC1) 3, 4, 6, 7 , and uses a distinct beclin 1 (BECN1) and VPS34 complex complex lacking ATG14 (ref. . These requirements for LAP and canonical autophagy can therefore distinguish between the two processes (Supplementary Table 1 ). As many components of autophagy are required for development (for example, FIP200 (refs 11, 12) and BECN1 (ref. 12)) or post-natal survival (for example, ATG14 (refs 12, 13), ATG7 (ref. 12), ATG5 (ref. 12) and ATG16L (ref. 12)), we generated animals in which several autophagy genes were conditionally ablated using lysozyme M (LysM, also known as Lyz2)-Cre recombinase 14
, as markers of a predisposition for SLE. Here we describe the consequences of defective LAP in vivo. Mice lacking any of several components of the LAP pathway show increased serum levels of inflammatory cytokines and autoantibodies, glomerular immune complex deposition, and evidence of kidney damage. When dying cells are injected into LAP-deficient mice, they are engulfed but not efficiently degraded and trigger acute elevation of pro-inflammatory cytokines but not anti-inflammatory interleukin (IL)-10. Repeated injection of dying cells into LAP-deficient, but not LAP-sufficient, mice accelerated the development of SLE-like disease, including increased serum levels of autoantibodies. By contrast, mice deficient in genes required for canonical autophagy but not LAP do not display defective dying cell clearance, inflammatory cytokine production, or SLE-like disease, and, like wild-type mice, produce IL-10 in response to dying cells. Therefore, defects in LAP, rather than canonical autophagy, can cause SLE-like phenomena, and may contribute to the pathogenesis of SLE.
LAP is a process in which some, but not all components of the autophagy machinery conjugate LC3 to phosphatidylethanolamine directly on the phagosome membrane 3, 4, 6, 7, 10 . The lipidated LC3 (LC3-II) then facilitates lysosomal fusion and cargo destruction. Both LAP and canonical autophagy require ATG7, ATG3, ATG5, ATG12, and ATG16L for LC3 lipidation 4, 5 . However, unlike autophagy, LAP proceeds independently of the pre-initiation complex containing ULK1 and FIP200 (also known as RB1CC1) 3, 4, 6, 7 , and uses a distinct beclin 1 (BECN1) and VPS34 complex complex lacking ATG14 (ref. 5) . By contrast, LAP, but not canonical autophagy, requires NADPH oxidase-2 (NOX2) 5 , and rubicon (RUBCN) 5 . These requirements for LAP and canonical autophagy can therefore distinguish between the two processes (Supplementary Table 1 ). As many components of autophagy are required for development (for example, FIP200 (refs 11, 12) and BECN1 (ref. 12)) or post-natal survival (for example, ATG14 (refs 12, 13) , ATG7 (ref. 12) , ATG5 (ref. 12 ) and ATG16L (ref. 12)), we generated animals in which several autophagy genes were conditionally ablated using lysozyme M (LysM, also known as Lyz2)-Cre recombinase 14 , affecting macrophages (CD11b + F4/80 + ), monocytes (CD11b + CD115 + ), some neutrophils (CD11b + Ly6G + ), and some conventional dendritic cells (CD11b + CD11c + ), but not eosinophils, plasmacytoid dendritic cells, or lymphocytes (Extended Data Fig. 1a, b) . While all animals appeared normal at weaning, we observed that LAPdeficient genotypes failed to gain weight compared to their wild-type littermates (Fig. 1a) . This effect was observed in animals lacking proteins required for both LAP and autophagy (ATG7, ATG5, BECN1) or LAP alone (NOX2, RUBCN), but not in animals lacking proteins required for autophagy but dispensable for LAP (FIP200, ULK1). Compared to LAP-sufficient animals, LAP-deficient mice displayed increased levels of circulating lymphocytes, monocytes and neutrophils (Extended Data Fig. 2a-c) , with increased circulating activated CD8 + T cells (Extended Data Fig. 2b , c), and augmented immunohistological staining of CD3 and Ki67 in the spleen (Extended Data  Fig. 2d ). Notably, LAP-deficient animals also contained increased serum levels of anti-double-stranded DNA (dsDNA) antibodies and anti-nuclear antibodies (Fig. 1b, c) , as well as a broad array of antibodies against autoantigens commonly associated with SLE ( Fig. 1d and Extended Data Fig. 3 ). LAP-deficient animals also presented with IgG and complement C1q deposition in the glomeruli of kidneys ( Fig. 2a-d, Extended Data Fig. 4a, b) . In addition, LAP-deficient animals displayed indications of kidney damage 15 , and exhibited increased functional markers of kidney injury, such as increased serum creatinine (Fig. 2e) , blood urea nitrogen, and proteinuria (Extended Data Fig. 4c, d ). Histologically, kidneys from aged LAP-deficient animals displayed endocapillary proliferative glomerulonephritis (Extended Data Fig. 4e ). Increased expression of type I interferon (IFN)-regulated genes, termed the IFN signature, has been reported in SLE patients 16 . Analysis revealed increased expression of IFN signature genes, such as Ddx58 (which encodes RIG-I) and Isg95 (also known as Cmtr1), in the spleens of aged LAP-deficient animals (Extended Data Fig. 5a ). By contrast, none of these pathologies was observed in animals lacking autophagy components dispensable for LAP (Fig. 2a-e and Extended Data Figs 4a-e, 5a). Collectively, these observations suggest that LAP deficiency, but not autophagy deficiency, causes an autoinflammatory, lupus-like syndrome in mice.
The kinetics of disease we observed in all LAP-deficient animals was markedly similar to that of animals lacking T-cell immunoglobulin mucin protein 4 (TIM4) (Figs 1a, b and 2a, e). TIM4 is required for engulfment of dying cells in several macrophage populations, and animals lacking TIM4 display lupus-like disease 2 , as do animals defective for other proteins involved in the clearance of dying cells, including MERTK, MFG-E8, and C1q (ref. 1). However, we found that neither bone-marrow-derived macrophages (Extended Data Fig. 5b ) nor peritoneal exudate macrophages from 52-week-old mice of any genotype (Extended Data Fig. 5c ) showed any defects in the engulfment of dying cells in vitro. We therefore examined the role of LAP in the response
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to dying cells in vivo. PKH26-labelled wild-type C57Bl/6 thymocytes were ultraviolet (UV)-irradiated to trigger apoptosis and immediately injected into wild-type animals, or animals with LysM-Cre-mediated deficiency of ATG7 (LAP-deficient, autophagy-deficient), LysMCre-mediated deficiency of FIP200 (LAP-sufficient, autophagydeficient), or ubiquitous deletion of RUBCN (LAP-deficient, autophagy-sufficient), all of which also expressed transgenic green fluorescent protein (GFP)-tagged LC3 (ref. 5). Clearance of dying thymocytes and induction of LC3-II (a measure of LC3 conversion 5 ) were monitored in spleen, liver and kidney. While both wild-type and animals with FIP200-deficiency effectively cleared dying cells (Fig. 3a, b and Extended Data Fig. 6a ) and converted GFP-LC3 (Extended Data Fig. 6b-d) , animals with ATG7-or RUBCN-deficiency did not, despite engulfment (Fig. 3a, b and Extended Data Fig. 6a, b, d , e). These data are consistent with our observations in vitro 4 , and support the conclusion that LAP is required for effective degradation of engulfed, dying cells in vivo. Data Fig. 6e ). However, while the frequency of engulfment declined by 48 h in all cellular subsets in wild-type mice, they remained elevated in Rubcn −/− mice, consistent with a failure of a LAP-dependent mechanism to degrade engulfed corpses (Extended Data Fig. 6e ).
Previously, we had found that in contrast to wild-type or Ulk1
−/− macrophages, Cre + Atg7 f/f macrophages produce increased levels of inflammatory cytokines, such as IL-1β and IL-6 in vitro 4 . We therefore examined cytokine production after ingestion of dying cells in macrophages lacking different components of the LAP or autophagy pathways (Extended Data Fig. 7a-d Fig. 7a-c) . Conversely, LAP-sufficient, but not LAPdeficient macrophages produced IL-10 upon engulfment (Extended Data Fig. 7d ). We then examined the effects of dying cells on serum cytokine production in vivo, after injection of UV-irradiated thymocytes (Fig. 3c, d) . Notably, serum IL-1β, IL-6 and MIP-1β (also known as CCL4) were acutely increased in LAP-deficient animals (ATG7 or RUBCN), but not in LAP-sufficient animals (wild-type or FIP200) (Fig. 3c, d ). As observed in vitro, LAP-sufficient animals produced increased serum IL-10 in response to dying cells, whereas LAP-deficient animals did not (Fig. 3c, d) . Therefore, LAP, but not canonical autophagy, is required for the production of IL-10 in response to apoptotic cell engulfment, and LAP suppresses the production of inflammatory cytokines under these conditions.
We next asked whether repeated injection of apoptotic thymocytes into LAP-deficient animals could exacerbate the SLE-like phenotype observed in aged LAP-deficient animals. LETTER RESEARCH increase in anti-nuclear antigens (ANA) and anti-dsDNA autoantibodies after 8 weeks, and no increase attributable to injection of dying cells. Rubcn −/− animals, however, displayed a significant increase in serum levels of ANA and anti-dsDNA autoantibodies after 8 weeks of dying cell injections, above pre-injection and age-matched, uninjected controls (Fig. 3e) . Furthermore, these animals displayed IgG and C1q deposition in the glomeruli of kidneys (Extended Data Fig. 8a, b) , and injected Rubcn −/− animals displayed increased levels of alanine aminotransferase, indicative of tissue damage (Extended Data Fig. 8c ). Collectively, these data demonstrate that defective dead cell clearance associated with LAP deficiency can result in development of SLE-like disease.
We next examined spontaneous levels of serum cytokines with age in animals with or without LAP. All genotypes lacking LAP (
) displayed increased levels of IL-1β, IL-6, IL-12p40 and IP-10 ( Fig. 4a-d) , as well as KC (also known as CXCL1), MIP-1β and MCP-1 (also known as CCL2) (Extended Data Fig. 8d-f ). Wild-type animals and animals lacking canonical autophagy, but not LAP (in monocytes or systemically), did not display increased inflammatory cytokines at any time point (Fig. 4a-d and Extended Data Fig. 8d-f ). By contrast, serum IL-10 levels, which increased with age in LAP-sufficient strains, were undetectable in animals lacking LAP (Fig. 4e) . The patterns and kinetics of cytokine levels were similar to that observed in Tim4 −/− animals ( Fig. 4a-e and Extended Data Fig. 8d-f ).
Our observations indicated that defects in LAP, but not canonical autophagy, cause an autoinflammatory, lupus-like syndrome in mice.
To test this idea further, we examined both LAP-sufficient and LAPdeficient mice bred in an independent facility. Mice with ATG5-or ATG3-deficient myeloid cells (defective in LAP and autophagy) displayed increased levels of IL-1β, IL-6, IL-12p40, IP-10, KC, MIP-1β and MCP-1 at 52 weeks of age (Extended Data Fig. 9a-g ). These LAPdeficient animals also displayed significantly lower levels of IL-10 than controls (Extended Data Fig. 9h ). Furthermore, LAP-deficient animals displayed elevated anti-dsDNA antibodies (Extended Data Fig. 9i ) and serum creatinine (Extended Data Fig. 9J ). LAP-deficient animals also contained a broad array of antibodies against autoantigens commonly associated with SLE (Extended Data Fig. 10 ). Of note, none of these effects was observed in animals with ATG14-or FIP200-deficiency (defective autophagy but normal LAP 3, 6, 7, 11, 13 ) (Extended Data Figs 9a-j, 10). It is noteworthy that these effects in two different facilities were observed in C57Bl/6 background animals, which are generally resistant to lupus-like disease 17 . Previous studies have shown that one of the LAP-deficient genotypes, Nox2 −/− , causes accelerated, severe lupus-like disease when bred on the lupus-prone MRL.lpr background 18 . Altogether, these data suggest that defective LAP results in a failure to digest engulfed dying cells, leading to increased inflammatory cytokine production and a lupus-like syndrome. In another study, animals in which lung macrophages were incapable of engulfment owing to deletion of RAC1 were sensitive to inflammatory cytokine production and inflammatory disease after introduction of dying cells into the lung 19 . Similarly, TIM4-deficient mice, which exhibit defective dead cell (n = 4, *P < 0.001, **P < 0.05, Student's t-test). e, 2 × 10 7 UV-irradiated wild-type thymocytes were injected intravenously six times over 8 weeks into indicated animals (aged 6 weeks). Serum anti-nuclear antibodies (total Ig) and anti-dsDNA antibodies (total Ig) are shown at 16 weeks from uninjected (uninj.) and injected (+AT) animals. Results are presented as ratio to average value before injection for each individual animal. Error bars represent s.e.m. (n = 4, **P < 0.05, Student's t-test). The colour scheme represents LAP-deficient, autophagydeficient genotypes (green), autophagy-deficient, LAP-sufficient (red), and autophagy-sufficient, LAP-deficient (blue). 16 , showed spontaneous increases in serum inflammatory cytokines with age ( Fig. 4 and Extended Data Fig. 8 ) as well as lupuslike disease (Figs 1 and 2) . By contrast, macrophages defective for LAP engulf dying cells, but fail to digest them efficiently 4, 7 . This suggests that LAP-dependent digestion of dying cells, rather than engulfment alone, suppresses an inflammatory response by macrophages. In the absence of LAP (lack of BECN1, ATG7, ATG5, NOX2, RUBCN), macrophages engulf dying cells and produce inflammatory cytokines, and animals manifest lupus-like disease. However, when canonical autophagy, but not LAP, is defective (lack of FIP200, ULK1), dying cells are engulfed, macrophages produce IL-10 but not inflammatory cytokines, and no lupus-like disease is observed.
MRL.lpr mice lacking IL-10 display markedly accelerated lupus-like disease 20 . While macrophages, monocytes and B cells are the major source of IL-10, specific deletion of IL-10 in B cells had no effect on pathogenesis in MRL.lpr mice 21 . Notably, one study found that injection of dendritic cells that had engulfed necrotic cells into IL-10-deficient, but not wild-type mice induced a pronounced lupus-like disease 22 . Thus, the role of LAP in the production of IL-10 may contribute to the disease effects we observed. However, most studies have implicated increased IL-10 levels in mouse and human SLE 20, 23, 24 , perhaps involved with the activation of B lymphocytes 25 . While IL-10 production in response to dying cells was compromised in LAPdeficient macrophages, the production of IL-10 in response to other stimuli may remain intact, and thus increased IL-10 in SLE may be due to other events in the pathogenesis of SLE.
Genome-wide association studies have implicated autophagy in SLE (Atg5 (refs 6, 8) and possibly Atg7 (ref. 9)) and in Crohn's disease (Atg16l; ref. 26) . It is notable in this context that the ATG5 association with SLE may depend on polymorphisms in IL- 10 (refs 8, 27) . Other studies have suggested that autophagy suppresses the inflammasome 28 , providing a possible link between autophagy and inflammatory disease. However, the autophagic components identified in these studies are also required for LAP. Furthermore, mice 18 and humans 29 lacking NOX2 develop SLE, and our studies suggest that defective LAP in this context may contribute to this effect. Our findings implicate a noncanonical autophagic process, LAP, in the control of inflammatory disease and suggest a link between the clearance of dying cells, autophagic processes, and inflammation in the control of SLE.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Bone-marrow-derived macrophages were generated from bone marrow progenitors obtained from littermates. Freshly prepared bone marrow cells were cultured in DMEM medium supplemented with 10% heat-inactivated FCS, 2 mM l-glutamine, 10 mM HEPES buffer, 50 μg ml −1 penicillin, and non-essential amino acids in the presence of 20 ng ml −1 rmM-CSF (Peprotech) for 6 days. Nonadherent cells were removed on day 6, and adherent macrophages were detached from plates and re-plated for experimental use. Ageing studies. Male wild-type and knockout littermates were co-housed and allowed to age for 52 weeks. Animals were weighed and bled retro-orbitally monthly, and serum was collected for use in assays (below). Numbers of animals were as follows (in all cases, Cre indicates LysM-Cre ). Thymocytes were washed twice with PBS before experimental use. Staining of apoptotic thymocytes and in vivo adoptive transfer of labelled apoptotic thymocytes. UV-treated thymocytes were stained with 20 M PKH26 Red (Sigma), per manufacturer's instructions. 1 × 10 7 PKH26-labelled, apoptotic thymocytes were injected intravenously into GFP-LC3 + animals, and serum, kidney, liver and spleen was collected at 0, 24, 48, 72 and 96 h after injection. Kidney sections were analysed for persistence of PKH26-labelled apoptotic cells using the Nikon800 microscope. Kidney, liver and spleen samples were analysed for PKH26-labelled apoptotic cells using flow cytometry. Additionally, samples were washed once with FACS buffer and permeabilized with digitonin (Sigma, 200 μg ml ) suspended in sterile phosphate buffer were injected intravenously (i.v.) into anaesthesized mice, once a week for four consecutive weeks (from weeks 1 to 4). After a resting period of 15 days, the injections were resumed and carried out for other 2 weeks (weeks 6 and 7). Serum was collected 1 week after the last injection (week 8) and assessed for levels of anti-dsDNA autoantibodies (total Ig), ANA (total Ig), and alanine aminotransferase. At week 8, mice were euthanized, the kidneys were collected and stained for immunofluorescence (below). Collection and co-culture of peritoneal exudate cells. For collection of peritoneal exudate cells, mice were injected intraperitoneally (i.p.) with 2 ml of 3% Brewer's thioglycollate and euthanized 96 h later. The peritoneum was washed with 10 ml ice-cold PBS three times. Cells were centrifuged (225g, 6 min, 4 °C) and washed twice with sterile PBS. Peritoneal exudate cells were resuspended in DMEM plus 10% FBS, counted and plated at 5 × 10 5 cells per well in a 12-well plate. Cells were allowed to settle for 2 h (37 °C, 5% CO 2 ) before co-culture with UV-irradiated wild-type thymocytes.

METHODS
Effects of dying cells on macrophages in vitro.
Apoptotic thymocytes were added to BMDM cultures at a ratio of 10:1 (dead cell:macrophage). Supernatant was collected after 24 h of culture and analysed for cytokines (see below). Flow cytometry analysis. Spleens, livers and kidneys were collected from animals at the indicated time points, and single-cell suspensions were generated. Cells were washed once with FACS buffer, and permeabilized with digitonin (Sigma, 200 μg ml −1 ) for 15 min on ice. Cells were then washed three times with FACS buffer and analysed by flow cytometry for membrane-bound GFP-LC3-II. This assay removes the soluble, cytosolic form of GFP-LC3 (GFP-LC3-I), while the lipidated, membrane-bound GFP-LC3-II is retained, allowing total GFP fluorescence to be used as a measure of LC3-II generation, indicative of LAP. Permeabilized samples were first gated on singlets/PKH26 + , so as to determine the MFI of GFP-LC3-II associated with cells that had engulfed a PKH26 + apoptotic thymocyte. For surface staining, blood, bone marrow or splenocytes were washed once with FACS buffer, incubated with Fc Block and stained with the indicated fluorescent antibodies (Biolegend) on ice for 20 min. Cells were then washed twice with FACS buffer and analysed by flow cytometry. Data were acquired using an LSRII cytometer (BD). Quantification of phagocytosis. Phagocytosis was quantified using flow cytometry analysis (described above). Apoptotic thymocytes were stained with CellTrace Violet (Molecular Probes) or PKH26 (Sigma-Aldrich) per manufacturer's protocol. Assessment of endocapillary proliferative glomerulonephritis. Kidneys were collected from 52-week-old mice. Organs were sectioned, fixed in 10% formalin, and embedded in paraffin. Four to six micrometre serial sections were cut, deparaffinized, rehydrated and stained with haematoxylin and eosin. All slides were coded before evaluation, and only decoded upon collection of all data. Endocapillary proliferative glomerulonephritis, a glomerular disease pattern frequently associated with lupus nephritis, was assessed on a virtual scale ranging from 0 to 5, where '0' was considered 'indistinguishable compared to wild type control' and '5' was considered 'the maximal damage seen in all samples' , based on the classification of glomerulonephritis in systemic lupus erythematosus. Features that influence this score are intraglomerular mesangial proliferation in relation to overall glomerular size, number of mesangial nuclei, intraluminal diameters of glomerular capillaries and the amount of mesangial matrix. Haematoxylinand-eosin-stained sections were used to score at least 24 glomeruli in a maximum of 4 different specimens obtained from each group. Detection of anti-dsDNA antibodies and ANA. The presence of anti-dsDNA antibodies in serum was tested using Mouse Anti-dsDNA Igs (Total A+G+M) ELISA Kit (Alpha Diagnostics International), per manufacturer's protocol. The presence of ANA in serum was tested using Mouse ANA/ENA Igs (Total A+G+M) ELISA Kit (Alpha Diagnostics International), per manufacturer's protocol. Detection of circulating autoantigen using autoantigen microarray. Autoantibody reactivities against a penal of 124 autoantigens were measured using an autoantigen microarray platform developed by University of Texas Southwestern Medical (https://microarray.swmed.edu/products/category/ protein-array/). In brief, serum samples were pretreated with DNase-I and then diluted 1:50 in PBS plus 0.05% Tween-20 buffer for autoantibody profiling. The autoantigen array bearing 124 autoantigens and 4 control proteins were printed in duplicates onto Nitrocellulose film slides (Grace Bio-Labs). The diluted serum samples were incubated with the autoantigen arrays, and autoantibodies were detected with Cy3-labelled anti-mouse IgG and Cy5-labelled anti-mouse IgM using a Genepix 4200A scanner (Molecular Device) with laser wavelength of 532 nm and 635 nm. The resulting images were analysed using Genepix Pro 6.0 software (Molecular Devices). The median of the signal intensity for each spot was calculated and subtracted the local background around the spot, and data obtained from duplicate spots were averaged. The background subtracted signal intensity of each antigen was normalized to the average intensity of the total mouse IgG, which was included on the array as an internal control. Finally, the net fluorescence intensity for each antigen was calculated by subtracting a PBS control that was included for each experiment as negative control. The signal-to-noise ratio was used as a quantitative measurement of the true signal above background noise. Signal-to-noise ratio values equal to or greater than 3 were considered significantly higher than background, and therefore true signals. The net fluorescence intensity of each autoantibody was used to generate heatmaps using Cluster and Treeview software (http://bonsai.hgc.jp/~mdehoon/software/cluster/software.htm). Each row in the heatmap represents an autoantibody, and each column represents a sample. Red colour represents the signal intensity higher than the mean value of the raw, and green colour means signal intensity is lower than the mean value of the raw. RNA extraction and nanostring analysis. Total RNA was isolated from the spleens from 52-week-old mice using NucleoSpin II kit (Macherey-Nagel) according to the manufacturer's instructions, and 50 ng was used to determine the absolute levels of gene expression. Hybridization and nCounter were performed according to the manufacturer's protocol (Nanostring Technologies). In brief, reactions were hybridized for 20 h at 65 °C, after which the products were used to run on the nCounter preparation station for removal of excess probes. Data were collected with the nCounter digital analyser by counting individual barcodes. Data generated from the nCounter digital analyser were examined with the nCounter digital analyser software system v2.1.1 (Nanostring Technologies). Data were normalized to the geometric means of spiked-in positive controls (controls for assay efficiency) and spiked-in negative controls (normalized for background). The data were further normalized to the housekeeping genes Gapdh, Hprt and Tubb5 and are reported as normalized RNA counts (means ± s.e.m.). Nanostring RNA counts were analysed with the Partek Genomic Suite, to identify significantly regulated probe. Heatmaps of Nanostring data were generated with the Partek Genomic Suite. Statistical analysis. The statistical significance of differences in mean values was calculated using unpaired, two-tailed Student's t-test. P values less than 0.05 were considered statistically significant. No statistical methods were used to predetermine sample size. Experiments were not randomized, and the investigators were not blinded to allocation during experiments and outcome assessment. (n = 5, **P < 0.05, Student's t-test). d, Spleens from wild-type and deficient littermates aged for 52 weeks were stained for anti-CD3 (top) or Ki67 (bottom) using immunohistochemistry. Representative images (original magnification, ×2.5) are shown (n = 4 per genotype). Error bars represent s.d. The colour scheme throughout represents LAP-deficient, autophagydeficient genotypes (green), autophagy-deficient, LAP-sufficient (red), and autophagy-sufficient, LAP-deficient (blue).
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